Skip to main content
Taylor & Francis Group Logo
Advanced Search

Click here to search books using title name,author name and keywords.

  • Login
  • Hi, User  
    • Your Account
    • Logout
Advanced Search

Click here to search books using title name,author name and keywords.

Breadcrumbs Section. Click here to navigate to respective pages.

Book

Pharmacoeconomics

Book

Pharmacoeconomics

DOI link for Pharmacoeconomics

Pharmacoeconomics book

From Theory to Practice

Pharmacoeconomics

DOI link for Pharmacoeconomics

Pharmacoeconomics book

From Theory to Practice
Edited ByRenée J.G. Arnold
Edition 2nd Edition
First Published 2020
eBook Published 26 August 2020
Pub. Location New York
Imprint CRC Press
DOI https://doi.org/10.1201/9780429491368
Pages 334
eBook ISBN 9780429491368
Subjects Bioscience, Health and Social Care, Physical Sciences
Share
Share

Get Citation

Arnold, R.J.G. (Ed.). (2020). Pharmacoeconomics: From Theory to Practice (2nd ed.). CRC Press. https://doi.org/10.1201/9780429491368

ABSTRACT

In this era of finite budgets, healthcare rationing, medication shortages, and the global aging and burgeoning of populations, numerous stakeholders in the healthcare arena must understand the basic principles of pharmacoeconomics and how these may be correctly applied to facilitate drug development, rationing, patient segmentation, disease management, and pricing model development.

Pharmacoeconomics: From Theory to Practice, Second Edition focuses on how to more efficiently and rationally leverage these healthcare resources, not by restricting access to necessary services, but by using them more efficiently. This updated volume arms decision makers with the tools they need to make wise choices in an area where the stakes are extremely high—the health of the global population.

Key Features:

  • Introduces the major concepts and principles of Pharmacoeconomics
  • Gives updated information about pharmacoeconomic models, value-based pricing, novel modelling methodologies and international utilization of these modalities in government, the pharmaceutical industry, and health care settings
  • Demonstrates the full range of ethical and moral issues, as well as overall public health and commercial concerns that are often involved in decisions entailing pharmacoeconomic issues
  • Presents both theory and methodology discussions, including real-world examples, in each chapter

'The methods and application of  pharmacoeconomics are rapidly evolving, so the new edition of this textbook is very timely. It provides an excellent introduction for those new to the field, whether they be students, professionals within the pharmaceutical industry, or health care professionals more generally. A particularly useful feature of the book is that it gives an introduction both to the main methods used in pharmacoeconomics studies and how these studies are used in decisions about the reimbursement or appropriate use of medicines in several countries.'

 - Michael Drummond, Professor of Health Economics, University of York

TABLE OF CONTENTS

chapter 1|20 pages

Introduction to Pharmacoeconomics

ByWilliam F. McGhan, Renée J.G. Arnold

chapter 2|22 pages

Decision Modeling Techniques

ByMark S. Roberts, Ken Smith

chapter 3|20 pages

Cost of Illness

ByRenée J.G. Arnold

chapter 4|16 pages

Markov Modeling in Decision Analysis

ByJ. Robert Beck, Elizabeth A. Handorf

chapter 5|29 pages

Retrospective Database Analysis

ByRenée J.G. Arnold, Sanjeev Balu

chapter 6|12 pages

What Is Cost-Minimisation Analysis?

ByAlan Haycox

chapter 7|15 pages

Cost-Effectiveness Analysis

ByKen Smith, Mark S. Roberts

chapter 8|16 pages

Budget Impact Analysis

ByJosephine Mauskopf, Lieven Annemans

chapter 9|17 pages

Multicriteria Decision Analysis for the Healthcare Decision Maker

BySumitra Sri Bhashyam, Kevin Marsh

chapter 10|18 pages

DICE Simulation

A Unifying Modeling Approach for Pharmacoeconomics
ByJ. Jaime Caro, Jörgen Möller

chapter 11|17 pages

Some Problems/Assumptions in Pharmacoeconomic Analysis

ByStuart Birks, Alan Haycox

chapter 12|22 pages

Patient-Reported Outcome Measures

ByDianne Bryant, Andrew Firth, Gordon Guyatt, Renée J.G. Arnold

chapter 13|12 pages

Sensitivity Analysis

ByMaarten J. Postma

chapter 14|13 pages

Use of Pharmacoeconomics in Drug Reimbursement 1

What Can We Learn from International Experience?
ByChris Sampson, Margherita Neri, Kyann Zhang

chapter 15|10 pages

Value-Based Pricing of Pharmaceuticals in the US and Europe

ByRenée J.G. Arnold, Neil X. Hawkins

chapter 16|13 pages

Pharmacoeconomics in Disease Management

Practical Applications and Persistent Challenges
ByRyung Suh, David Atkins

chapter 17|16 pages

From Machine Learning in Drug Discovery to Pharmacoeconomics

BySean Ekins, Renée J.G. Arnold

chapter 18|9 pages

Speculations on the Future Challenges and Value of Pharmacoeconomics

ByJ. Jaime Caro

chapter 19|6 pages

Pharmacoeconomics in the Era of the Novel Coronavirus

ByRenée J.G. Arnold
T&F logoTaylor & Francis Group logo
  • Policies
    • Privacy Policy
    • Terms & Conditions
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
    • Cookie Policy
  • Journals
    • Taylor & Francis Online
    • CogentOA
    • Taylor & Francis Online
    • CogentOA
  • Corporate
    • Taylor & Francis Group
    • Taylor & Francis Group
    • Taylor & Francis Group
    • Taylor & Francis Group
  • Help & Contact
    • Students/Researchers
    • Librarians/Institutions
    • Students/Researchers
    • Librarians/Institutions
  • Connect with us

Connect with us

Registered in England & Wales No. 3099067
5 Howick Place | London | SW1P 1WG © 2021 Informa UK Limited